Southern Africa — Gus Attridge — South Africa — Johannesburg Stock Exchange — Aspen Pharmacare — Hot News
Gus Attridge’s stake in Africa’s largest pharma company drops by $16.5 million
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Related
FirstRand’s Mary Vilakazi took home $2.2 million in 2024
This remuneration reflects her instrumental role in steering the company’s growth and maintaining its industry dominance.
South African billionaire Jannie Mouton gains $352 million from Capitec shares
Capitec’s strong returns have solidified its position as one of the JSE’s top performers in 2024, offering a 56.29 percent return year-to-date.
South African Reserve Bank sanctions Michiel Le Roux's Capitec Bank
Despite the sanctions, Capitec maintained cooperation in its remedial measures to address compliance weaknesses and enhance its AML framework.
Thungela to acquire remaining interest in Ensham business for $29.9 million
Thungela secures full Ensham ownership, reinforcing its Asia-Pacific presence and boosting coal exports to Japan and Malaysia.
Latest
Beltone approves $211 million to power expansion and growth goals
The fresh funds will support Beltone's initiatives to deepen its capabilities and strengthen its competitive positioning in the MENA region’s fast-evolving financial services sector.
Madinet Masr secures $177 million for Egypt’s development projects
The development projects, which are set to generate more than five million jobs, will help bridge the housing gap.
FirstRand’s Mary Vilakazi took home $2.2 million in 2024
This remuneration reflects her instrumental role in steering the company’s growth and maintaining its industry dominance.
Vitafoam Nigeria’s profit slumps amid naira devaluation, revenue rises 56%
Vitafoam expands ECOWAS presence with strong Sierra Leone market acceptance, overcoming local financial challenges.